| |
| |
|
| Insider
Information: |
Sjuts Dustin S |
| Relationship: |
President |
| City: |
Newark |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
167,550 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$569,670 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
167,550 |
|
|
| Total
Value |
$569,670 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Revance Therapeutics, Inc. |
RVNC |
President |
2024-03-18 |
167,550 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2024-03-18 |
4 |
S |
$5.04 |
$46,446 |
D/D |
(9,211) |
167,550 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2024-03-15 |
4 |
D |
$5.31 |
$15,740 |
D/D |
(2,967) |
176,761 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2024-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
22,110 |
179,728 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2023-12-31 |
4 |
A |
$7.47 |
$1,972 |
D/D |
264 |
157,618 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2023-12-15 |
4 |
D |
$8.08 |
$38,073 |
D/D |
(4,712) |
157,354 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2023-08-11 |
4 |
D |
$18.91 |
$168,318 |
D/D |
(8,901) |
162,066 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
22,620 |
170,967 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2023-06-30 |
4 |
A |
$15.61 |
$15,606 |
D/D |
1,000 |
148,347 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2023-06-09 |
4 |
AS |
$30.82 |
$154,096 |
D/D |
(5,000) |
147,347 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2023-05-15 |
4 |
S |
$34.55 |
$726,003 |
D/D |
(21,015) |
152,347 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2023-03-15 |
4 |
D |
$30.65 |
$90,939 |
D/D |
(2,967) |
120,967 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2023-03-09 |
4 |
S |
$31.59 |
$679,358 |
D/D |
(21,508) |
123,934 |
0 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2023-02-15 |
4 |
D |
$33.21 |
$91,859 |
D/D |
(2,766) |
93,046 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2022-12-31 |
4 |
A |
$12.18 |
$7,369 |
D/D |
605 |
95,812 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2022-12-15 |
4 |
D |
$21.50 |
$62,694 |
D/D |
(2,916) |
95,207 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2022-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
52,396 |
145,442 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2022-06-30 |
4 |
A |
$11.75 |
$11,747 |
D/D |
1,000 |
98,123 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2022-03-15 |
4 |
D |
$15.79 |
$28,975 |
D/D |
(1,835) |
97,123 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2022-02-15 |
4 |
D |
$13.35 |
$32,427 |
D/D |
(2,429) |
98,958 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2022-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
52,395 |
173,362 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2021-12-15 |
4 |
D |
$15.92 |
$8,167 |
D/D |
(513) |
101,387 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
President |
• – – |
2021-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
35,920 |
101,900 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
• – – |
2021-06-30 |
4 |
A |
$24.09 |
$21,246 |
D/D |
882 |
65,980 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
• – – |
2021-04-15 |
4 |
D |
$28.16 |
$11,574 |
D/D |
(411) |
65,098 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
• – – |
2021-02-15 |
4 |
D |
$28.97 |
$69,818 |
D/D |
(2,410) |
65,509 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
